Taylor Wessing advised Shield Therapeutics on securing $26 million debt and equity fundraising. Shield Therapeutics plc, a specialty pharmaceutical company listed on AIM, has secured a...
Shield Therapeutics’ $26m Debt and Equity Fundraising
Inflexion’s Investment in TC Group
Taylor Wessing advised leading mid-market private equity firm Inflexion on its investment. Inflexion, a prominent mid-market private equity firm, has made a strategic investment in TC...
Flight Centre’s Acquisition of Scott Dunn
Travers Smith LLP and King & Wood Mallesons advised Flight Centre on the deal. Taylor Wessing advised Scott Dunn. Flight Centre planned to raise approximately $220 million to...
Shield Therapeutics plc’s Debt and Equity Fundraise
Taylor Wessing advised Shield Therapeutics plc on the deal. Shield Therapeutics plc, an AIM-listed commercial stage specialty pharmaceutical company, extended an existing convertible debt facility by $10...
Inflexion’s Investment in K2 Partnering Solutions
White & Case advised Inflexion Private Equity Partners on the acquisition financing aspects of the deal. Taylor Wessing advised K2 Partnering Solutions. Inflexion Private Equity Partners...